Cited by 11Gout, Hyperuricemia, Uric AcidAngiogenesis and VEGF in CancerNitric Oxide and Endothelin Effects

Chronic Hyperuricemia Impairs Blood Flow Recovery in the Ischemic Hindlimb through Suppression of Endothelial Progenitor Cells

Open access
Chen, I-Chun, Kuo, Chin-Sung, Wu, Chih-Cheng, Tsai, Hsiao-Ya, Lin, Chih-Pei, Li, Szu-Yuan, Chou, Ruey-Hsing, Huang, Po-Hsun +2 more·2018·Oncotarget

Abstract

// I-Chun Chen 1 , Chin-Sung Kuo 1, 2 , Chih-Cheng Wu 3, 4, 5, 6 , Hsiao-Ya Tsai 1 , Chih-Pei Lin 7, 8 , Szu-Yuan Li 1, 9 , Ruey-Hsing Chou 1, 3, 10 , Po-Hsun Huang 1, 3, 10 , Jaw-Wen Chen 3, 10, 11, 12 and Shing-Jong Lin 1, 3, 10, 11, 13 1 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan 2 Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 3 Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan 4 National Tsing-Hua University, Institute of Biomedical Engineering, Hsinchu, Taiwan 5 National Taiwan University Hospital, College of Medicine, Taipei, Taiwan 6 Cardiovascular Center, National Taiwan University Hospital, Hsinchu Branch, Hsinchu, Taiwan 7 Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 8 Department of Biotechnology and Laboratory Science in Medicine and Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei, Taiwan 9 Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 10 Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 11 Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan 12 Institute and Department of Pharmacology, National Yang-Ming University, Taipei, Taiwan 13 Taipei Medical University, Taipei, Taiwan Correspondence to: Po-Hsun Huang, email: huangbsvgh@gmail.com Chih-Cheng Wu, email: chihchengwumd@gmail.com Chin-Sung Kuo, email: cskuo241@yahoo.com.tw Keywords: hyperuricemia; endothelial progenitor cell; ischemia; neovascularization Received: August 14, 2017 Accepted: January 02, 2018 Published: January 22, 2018 ABSTRACT Objective: Chronic hyperuricemia is associated with cardiovascular disease, but its impact on endothelial progenitor cells (EPC) and ischemia-induced neovascularization remains unclear. Herein we investigated whether chronic hyperuricemia could impede blood flow recovery in response to tissue ischemia by suppression of EPC. Methods: Human EPC were isolated and cultured in a high-level uric acid medium for functional testing. Cell proliferation, nitric oxide (NO) production and apoptosis assay were examined. A chronic hyperuricemia mouse model was established by potassium oxonate treatment and/or a high-level uric acid diet to evaluate the actions of chronic hyperuricemia on ischemia-induced blood flow recovery. After 4 weeks of drug treatment, hindlimb ischemia surgery was performed in the control and hyperuricemia mice. Blood flow recovery was followed up every week before and after ischemic surgery using a laser Doppler Perfusion Imager System. The circulating EPC number in the peripheral blood was determined by flow cytometry (Sca-1 + /Flk-1 + ). Results: Incubation with a high-level uric acid medium (10 mg/dL) significantly suppressed EPC proliferation, reduced NO production, and lessened phosphorylation of Akt and eNOS. Moreover, EPC treated with high-level uric acid increased reactive oxygen species production, promoted cellular apoptosis and senescence, and also inhibited EPC tube formation. Four weeks after hindlimb ischemia surgery, the chronic hyperuricemia mice had significantly reduced tissue reperfusion, EPC mobilization, and impaired neovascularization in the ischemic hindlimbs compared with the control mice. Conclusions: Chronic hyperuricemia impaired blood flow recovery and EPC mobilization in response to tissue ischemia, and these effects could have occurred through suppression of EPC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.24290

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vitro studies reported increased cellular senescence and enhanced ROS production in endothelial progenitor cells cultured in medium containing UA at high concentrations (10 mg/dL).

    “Further, in vitro studies have reported an increased cellular senescence and enhanced ROS production in endothelial progenitor cells cultured in a medium containing UA at high concentrations (10 mg/dL) [223].”
  • UA triggers OS-induced senescence through inhibition of eNOS, which is essential to produce the scavenging molecule NO.

    “At the molecular level, there is evidence that UA triggers OS-induced senescence through the inhibition of the enzyme eNOS, which is essential to produce the scavenging molecule NO [215,223].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, I.-C., Kuo, C.-S., Wu, C.-C., Tsai, H.-Y., Lin, C.-P., Li, S.-Y., Chou, R.-H., Huang, P.-H., Chen, J.-W., & Lin, S.-J.
Affiliations
  • National Yang Ming University (TW)
  • Taipei Veterans General Hospital (TW)
  • National Tsing Hua University (TW)
Corresponding author
Wu, Chih-Cheng
Venue
Oncotarget
Published
2018-01-22
Volume
9
Issue
10
Pages
9285-9298
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2791859505
Cited by
11
References
44
Citations by year
2023: 4 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1
FWCI
1.23
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Oncotarget (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Taiwan University Hospital
  • National Taiwan University
Topics
  • Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
endothelial progenitor cells, hindlimb ischemia, blood flow recovery, neovascularization, uric acid, angiogenesis, oxidative stress, nitric oxide synthase, nitric oxide, reactive oxygen species, endothelial dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review